Sponsored Content
Prepared for the Next Pandemic - Utilizing New Production Capacities for Streamlined Vaccine Mfg
This informative webinar on May 28th will delve into the critical aspects of pandemic preparedness, focusing on vaccine development and production.
More Content From IDT Biologika
-
Advancing Biologics. Protecting Life.
End-to-End Services in Contract Development & Manufacturing of Vaccines and Cell & Gene Therapeutics. Fill-Finish of Biologics and Sterile Injectables.Literature / Brochures Released on 02.26.2024
-
IDT Biologika Company Presentation
Contract Development and Manufacturing of Vaccines, Cell & Gene Therapeutics, Fill & Finish of Biologics.Literature / Brochures Released on 02.26.2024
-
IDT Biologika is increasing its production capacity of vaccines
Saxony-Anhalt's Prime Minister Reiner Haseloff visited the new facilitiesNews Releases Released on 01.21.2022
-
IDT Biologika Paper on Expanding Viral Vectors
Smart Scale-Up: Expanding Viral Vectors With Microcarrier Bead TechnologyWhite Papers / Tech Papers Released on 01.07.2022
-
IDT Biologika Paper on Viral Vectors and Vaccines
Viral Vectors, Vaccines - A New Era of Collaborative DesignWhite Papers / Tech Papers Released on 01.07.2022
-
IDT Biologika Paper on Developing Oncolytic Viruses
Best Practices For Oncolytic Virus Design, Development, and ManufacturingWhite Papers / Tech Papers Released on 01.07.2022
-
IDT Biologika on the Production of Inactivated COVID-19 Vaccine
Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19 Vaccine VLA2001News Releases Released on 01.07.2022
-
IDT Biologika Corporate Video
Single Source CDMO Partner for Clinical Test Material and Commercial ProductsVideos Released on 01.07.2022
-
VideoBites: IDT Biologika
IDT Biologika specializes in the production of innovative live viral vaccines, viral vectors for gene and immune therapeutics, oncolytic viruses and more.Videos Released on 08.12.2021
